X0202 SCHEDULE 13G/A 0002042077 XXXXXXXX LIVE 2 American Depositary Shares 03/24/2026 0001075880 KAZIA THERAPEUTICS LTD 48669G105 THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 Rule 13d-1(c) Chernett Jorey DE 1588129.00 0.00 1588129.00 0.00 1588129.00 N 13.90 IN KAZIA THERAPEUTICS LTD Three International Towers, Level 24, 300 Barangaroo Avenue, SYDNEY NSW, AUSTRALIA, 2000 Jorey Chernett (the "Reporting Person") The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301. US. Y The aggregate percentage of American Depositary Shares ("ADS") owned by the Reporting Person is calculated based upon 11,426,899 American Depository Shares outstanding as of March 12, 2026 (assuming all outstanding Ordinary Shares were represented by American Depository Shares), as disclosed in the Issuer's Registration Statement on Form F-3, filed with the U.S. Securities and Exchange Commission (the "SEC") on March 17, 2026. As of the close of business on February 19, 2026, the Reporting Person beneficially owned 1,588,129 ADS. 13.90% See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Chernett Jorey /s/ Jorey Chernett 03/31/2026